Some Drugs May Meet Guidelines for Accelerated Approval in Phase 2-3 Design Trials - 102134

Spotlight
Video

Some Drugs May Meet Guidelines for Accelerated Approval in Phase 2-3 Design Trials

SGO2017 has 36 videos Subscribe Here

Loading........
Description: Christina Annunziata, MD, PhD of National Institutes of Health discusses how some novel agents may meet the guidelines for accelerated approval in phase 2-3 design trials. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)’s Annual Meeting on Women’s Cancer® in National Harbor, MD.
Shared By : SGO2017
Posted on : 03/17/17
Added : 1 year ago
Category : General